tiprankstipranks
Trending News
More News >
Novartis Stock (NVS) Looks Healthier as it Spends $23B on Ramping Up U.S. Manufacturing
PremiumMarket NewsNovartis Stock (NVS) Looks Healthier as it Spends $23B on Ramping Up U.S. Manufacturing
10d ago
Novartis announces planned $23B investment over five years in U.S.
Premium
The Fly
Novartis announces planned $23B investment over five years in U.S.
11d ago
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
Premium
The Fly
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
12d ago
Needham healthcare analysts hold analyst/industry conference call
PremiumThe FlyNeedham healthcare analysts hold analyst/industry conference call
19d ago
FDA Approves Novartis’ Pluvicto for Early Use in Prostate Cancer Treatment
Premium
Company Announcements
FDA Approves Novartis’ Pluvicto for Early Use in Prostate Cancer Treatment
24d ago
FDA approves Novartis radioligand therapy Pluvicto for earlier use in mCRPC
Premium
The Fly
FDA approves Novartis radioligand therapy Pluvicto for earlier use in mCRPC
24d ago
Novartis gets third FDA approval for oral Fabhalta
PremiumThe FlyNovartis gets third FDA approval for oral Fabhalta
1M ago
Novartis’s treatment of leishmaniasis granted FDA orphan designation
Premium
The Fly
Novartis’s treatment of leishmaniasis granted FDA orphan designation
1M ago
Patient Fatality Forces Reality Check on Sarepta Therapeutics Stock (SRPT)
Premium
Market News
Patient Fatality Forces Reality Check on Sarepta Therapeutics Stock (SRPT)
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100